Parkinson’s Disease Therapeutics Market By Drug Class (Dopamine Agonists, Levodopa/ Caxrbidopa, Anticholinergic Drugs, Monoamine Oxidase B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors and Adenosine A2 Receptor Antagonist), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Growth, Future Prospects and Competitive Analysis, 2025 – 2033
